Optimization of therapeutic drugs for safety and efficacy is a delicate balancing act requiring chemical mod- ification of the drug candidate without altering it's therapeutic benefits. Knowledge of a drug's mechanism of action is critical for successful optimization. In prior work, we developed a novel approach for predict- ing drug mechanisms from gene expression profiles of drug activity. The method was pioneering in its use of a mathematical gene network model to analyze noisy, high-dimensional gene expression data. It was successfully applied in a preliminary study on yeast, but certain characteristics of our early work limit its accuracy and broader applicability. In particular, the modeling approach obscured biologi- cally meaningful network relationships, and could not incorporate prior data on gene network structure to improve predictions. In this project, we will develop statistical, computational, and experimental methods to extend and broaden our previous work on predicting drug mechanism of action from gene expression data.
In aims 1 -3, we will adapt the framework of simultaneous equation models (SEMs) to our problem and, within this context, develop extensions of recent techniques for sparse inference, both frequentist and Bayesian variants.
In aims 4 -6, we will test and validate the sparse SEM methods on a database of expression profiles that we will obtain by treating yeast with a large set of stresses and bioactive compounds. The resulting methods will enable rapid and inexpensive discovery of the mechanism of action of both candidate therapeutic compounds and hazardous biological toxins. This proposal includes innovative contributions in biology, bioinformatics, statistics, chemical biology and pharmacology. The work will make valuable contributions to the fields of systems biology and bioinformatics by demonstrating unique methodology for design and analysis of microarray experiments and the practical utility of genome-scale modeling of gene regulation. To the statistics community, this work will offer powerful extensions of the SEM framework, through its pairing with adaptive, sparse inference tools. For the chemical biology and pharmacology communities, this work will offer a valuable new method to determine the biological activity of novel compound classes. In addition, this work could substantially accelerate the development of safe and effective therapeutic drugs. It could provide a novel computational tool for quickly and cost-effectively evaluating the mechanism of action of chemical and biological agents of potential therapeutic value. Moreover, some of the compounds that we propose to study in this project are novel anticancer and antifungal compounds with therapeutic potential.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM078987-05
Application #
7798574
Study Section
Special Emphasis Panel (ZGM1-CBCB-5 (BM))
Program Officer
Lyster, Peter
Project Start
2006-04-01
Project End
2012-03-31
Budget Start
2010-04-01
Budget End
2012-03-31
Support Year
5
Fiscal Year
2010
Total Cost
$312,419
Indirect Cost
Name
Boston University
Department
Engineering (All Types)
Type
Schools of Engineering
DUNS #
049435266
City
Boston
State
MA
Country
United States
Zip Code
02215
Pham, Lisa M; Carvalho, Luis; Schaus, Scott et al. (2016) Perturbation Detection Through Modeling of Gene Expression on a Latent Biological Pathway Network: A Bayesian hierarchical approach. J Am Stat Assoc 111:73-92
Lu, Chen; O'Connor, George T; Dupuis, Josée et al. (2016) Meta-Analysis for Penalized Regression Methods with Multi-Cohort Genome-Wide Association Studies. Hum Hered 81:142-149
Christadore, Lisa M; Pham, Lisa; Kolaczyk, Eric D et al. (2014) Improvement of experimental testing and network training conditions with genome-wide microarrays for more accurate predictions of drug gene targets. BMC Syst Biol 8:7
Lu, Chen; Latourelle, Jeanne; O'Connor, George T et al. (2013) Network-guided sparse regression modeling for detection of gene-by-gene interactions. Bioinformatics 29:1241-9
Grant, Trevor J; Bishop, Joshua A; Christadore, Lisa M et al. (2012) Antiproliferative small-molecule inhibitors of transcription factor LSF reveal oncogene addiction to LSF in hepatocellular carcinoma. Proc Natl Acad Sci U S A 109:4503-8
Yang, Shu; Kolaczyk, Eric D (2010) Target Detection via Network Filtering. IEEE Trans Inf Theory 56:2502-2515
Thaden, Joshua T; Lory, Stephen; Gardner, Timothy S (2010) Quorum-sensing regulation of a copper toxicity system in Pseudomonas aeruginosa. J Bacteriol 192:2557-68
Cosgrove, Elissa J; Gardner, Timothy S; Kolaczyk, Eric D (2010) On the choice and number of microarrays for transcriptional regulatory network inference. BMC Bioinformatics 11:454
Faith, Jeremiah J; Driscoll, Michael E; Fusaro, Vincent A et al. (2008) Many Microbe Microarrays Database: uniformly normalized Affymetrix compendia with structured experimental metadata. Nucleic Acids Res 36:D866-70
Cosgrove, Elissa J; Zhou, Yingchun; Gardner, Timothy S et al. (2008) Predicting gene targets of perturbations via network-based filtering of mRNA expression compendia. Bioinformatics 24:2482-90

Showing the most recent 10 out of 12 publications